The 'Indirect' Effects of Cytomegalovirus Infection

被引:176
作者
Freeman, R. B., Jr. [1 ]
机构
[1] Tufts Med Ctr, Div Transplantat, Boston, MA USA
关键词
Cytomegalovirus (CMV); cytomegalovirus infection; immune modulation; ENDOTHELIAL-CELLS; ALLOGRAFT-REJECTION; DIABETES-MELLITUS; ENHANCER PROMOTER; ORAL GANCICLOVIR; HIGH PREVALENCE; DOWN-REGULATION; EXPRESSION; DISEASE; ORGAN;
D O I
10.1111/j.1600-6143.2009.02824.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Cytomegalovirus (CMV) remains the most important infection in the immunocompromized host even in the era of effective therapy. CMV is usually acquired early in life and can be transmitted by contact with infected body fluids. In the immunocompetent population, primary infection is almost always of little clinical consequence. However, CMV infection in immunocompromized patients, especially those naive to CMV exposure, can cause tissue invasive disease, severe symptoms and/or death. However, beyond these direct effects, increasing in vitro evidence is accumulating that suggests CMV has many other effects on the host's immune response which may explain some of the detrimental consequences for the immunosuppressed patient, and may also be partially responsible for a variety of conditions in immunocompetent individuals. In its latent state, CMV employs several mechanisms to evade detection by the host's immune system. The virus also employs other methods to take advantage of activation of the immune system and replicate in sites of inflammation. This review focuses on the immunosuppressive and inflammatory mechanisms that have been attributed to CMV and will relate them to some of the clinical sequellae that have been associated with the indirect effects of CMV infection.
引用
收藏
页码:2453 / 2458
页数:6
相关论文
共 60 条
[11]   Functional profiling of a human cytomegalovirus genome [J].
Dunn, W ;
Chou, C ;
Li, H ;
Hai, R ;
Patterson, D ;
Stolc, V ;
Zhu, H ;
Liu, FY .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (24) :14223-14228
[12]   Cytomegalovirus disease is associated with increased cost and hospital length of stay among orthotopic liver transplant recipients [J].
Falagas, ME ;
Arbo, M ;
Ruthazer, R ;
Griffith, JL ;
Werner, BG ;
Rohrer, R ;
Freeman, R ;
Lewis, WD ;
Snydman, DR .
TRANSPLANTATION, 1997, 63 (11) :1595-1601
[13]   Exposure to cytomegalovirus from the donated organ is a risk factor for bacteremia in orthotopic liver transplant recipients [J].
Falagas, ME ;
Snydman, DR ;
Griffith, J ;
Werner, BG ;
Rohrer, R ;
Freeman, R ;
Fawaz, K ;
Hoffman, MA ;
Kaplan, M ;
Gill, M ;
Rubin, RH ;
Dienstag, JL ;
Doran, M ;
ORourke, E ;
Vacanti, J ;
Jenkins, R ;
Lewis, WD ;
Hammer, S ;
Martin, M ;
Fairchild, R ;
Grady, GF ;
Leszczynski, J ;
Dougherty, N ;
Katz, A ;
Fausett, G ;
Platt, R ;
Cheeseman, SH ;
Pasternack, M ;
Gorbach, SL .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (03) :468-474
[14]   Infection in organ-transplant recipients [J].
Fishman, JA ;
Rubin, RH .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (24) :1741-1751
[15]  
Fletcher JM, 1998, J IMMUNOL, V161, P2365
[16]   Human Cytomegalovirus Paralyzes Macrophage Motility through Down-Regulation of Chemokine Receptors, Reorganization of the Cytoskeleton, and Release of Macrophage Migration Inhibitory Factor [J].
Frascaroli, Giada ;
Varani, Stefania ;
Blankenhorn, Nina ;
Pretsch, Robert ;
Bacher, Michael ;
Leng, Lin ;
Bucala, Richard ;
Landini, Maria Paola ;
Mertens, Thomas .
JOURNAL OF IMMUNOLOGY, 2009, 182 (01) :477-488
[17]  
GAO JL, 1994, J BIOL CHEM, V269, P28539
[18]   CYTOMEGALO-VIRUS INFECTION IS ASSOCIATED WITH CARDIAC ALLOGRAFT-REJECTION AND ATHEROSCLEROSIS [J].
GRATTAN, MT ;
MORENOCABRAL, CE ;
STARNES, VA ;
OYER, PE ;
STINSON, EB ;
SHUMWAY, NE .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (24) :3561-3566
[19]   Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer [J].
Harkins, L ;
Volk, AL ;
Samanta, M ;
Mikolaenko, I ;
Britt, WJ ;
Bland, KI ;
Cobbs, CS .
LANCET, 2002, 360 (9345) :1557-1563
[20]   Glucose intolerance after renal transplantation depends upon prednisolone dose and recipient age [J].
Hjelmesaeth, J ;
Hartmann, A ;
Kofstad, J ;
Stenstrom, J ;
Leivestad, T ;
Egeland, T ;
Fauchald, P .
TRANSPLANTATION, 1997, 64 (07) :979-983